Gavilimomab is a murine IgM monoclonal antibody (MoAb) developed as a potential treatment for graft-versus-host disease (GvHD). The DrugMonitor™ Anti-Gavilimomab Antibody (VS-1224-YC512) is an anti-drug antibody (ADA) against Gavilimomab. This drug-based antibody is raised in mice immunized with the Gavilimomab. The anti-Gavilimomab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Gavilimomab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-BSG ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-156)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD147. It is a mouse monoclonal antibody intended for use as an immunosuppressive biologic treatment of glucocorticoid-resistant graft versus host disease. It binds to the antigen CD147. It proved slightly less effective than standard antithymocyte globulin therapy.
There are currently no Customer reviews or questions for VS-1224-YC512. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.